Browse studies
Find your next paid study
112 recruiting studies matching your filters
Phase 1
A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabeled FAPi PET/CT Imaging Agent) in Patients With Sarcoma or Gastrointestinal Tract Cancer (PHANTOM Trial)
This is a multicenter, open-label, prospective Phase 1/2a study to assess safety and tolerability, establish dosimetry and to identify an optimal imaging dose …
Metastatic SarcomaEsophageal CancerGastric Cancer+3 more
Estimated
~$10 – $8,750
Lantheus Medical ImagingNCT06298916
Phase 4
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
This is an open-label study in adults to determine feasibility of using CYTALUX™ (pafolacianine) injection with near-infrared (NIR) fluorescent imaging for det…
Gastrointestinal CancerGastric CancerEsophageal Cancer+1 more
Estimated
~$10 – $6,250
Cedars-Sinai Medical CenterNCT07124351
Phase 1
A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors, Including Checkpoint Inhibitor Naïve Participants With Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors
The goal of this clinical trial is to determine the most effective dose of EIK1005 that a person can take safely. Additionally, this study will test how well E…
Advanced Solid TumorsMSI-H or dMMR Advanced Solid TumorsMSI-H/dMMR Gastric Cancer+4 more
Estimated
~$10 – $8,750
Eikon TherapeuticsNCT07262619
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers and Subjects Undergoing Lung Cancer Screening
Patients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despit…
Non Small Cell Lung CancerEsophageal CancerGastric Cancer+3 more
Estimated
~$10 – $750
University of Missouri-ColumbiaNCT03551951